Literature DB >> 2431047

A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.

S Kure, O Yoshie.   

Abstract

We have isolated a syngeneic monoclonal antibody (HepSS-1) reactive to a murine methylcholanthrene-induced fibrosarcoma, Meth-A. HepSS-1 also bound to a wide variety of established and fresh normal cells derived from not only mice but also other species such as human, monkey, rat, hamster, and chicken. Immunoprecipitation of surface iodinated Meth-A cell extract with HepSS-1, as well as Sepharose 4B gel chromatography of Meth-A cell extract and detection of antigens recognized by HepSS-1 by a sandwich-type radioimmunoassay revealed that the HepSS-1 antigens were composed of several molecular species, with one as large as approximately 10(6) daltons. The following evidence indicates that HepSS-1 specifically recognizes an epitope present in heparan sulfate glycosaminoglycan (HS-GAG). First, treatment of Meth-A cells with heparitinase or heparinase, but not with chondroitinase ABC or hyaluronidase, resulted in the loss of HepSS-1 binding. Second, HS-GAG but not seven other types of GAG (hyaluronic acid, heparin, chondroitin, chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate, and keratan sulfate) inhibited HepSS-1 binding to Meth-A cells. Third, HepSS-1 bound with HS-GAG but not with the seven other types of GAG. From the binding analysis of HepSS-1 to various modified HS-GAG and whale omega-heparin, it is additionally suggested that HepSS-1 recognizes an epitope closely related to O-sulfated and N-acetylated glucosamine. We found that NIH 3T3 cells expressed more HepSS-1 epitopes at a low cell density than at confluency and in G2 + M than in G1, whereas NIH 3T3 cells transformed with Kirsten-ras oncogene or SV-40 expressed high levels of HepSS-1 epitopes and ceased to show the density-dependent change in the amount of HepSS-1 epitopes. These observations were also reproduced by using NIH 3T3 cells transformed with a temperature sensitive Kirsten murine sarcoma virus maintained at permissive and non-permissive temperatures. Thus HepSS-1 is a first monoclonal antibody to HS-GAG and seems to be useful to elucidate changes in cell surface HS-GAG in normal cell growth and cell transformation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431047

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line.

Authors:  Jennifer Y C Cheng; John Whitelock; Laura Poole-Warren
Journal:  Histochem Cell Biol       Date:  2012-08-08       Impact factor: 4.304

2.  Sulfated glycoconjugate determinants recognized by monoclonal antibody, SG-1, correlate with the experimental metastatic ability of KHT fibrosarcoma cells.

Authors:  J F Harris; D W Beaton
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

3.  A human monoclonal IgM with autoantibody activities against heparan sulphate and the mitotic spindle.

Authors:  B Roussel; J Arvieux; M C Jacob; P Lorimier; E Cavigioli; C Micouin
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Immunohistochemical study of proteoglycans in D-galactosamine-induced acute liver injury in rats.

Authors:  S Sasaki; N Koide; T Shinji; T Tsuji
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

5.  Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

Authors:  Sophie M Thompson; Marilyn G Connell; Toin H van Kuppevelt; Ruoyan Xu; Jeremy E Turnbull; Paul D Losty; David G Fernig; Edwin C Jesudason
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

6.  Positive feedback regulation of frizzled-7 expression robustly shapes a steep Wnt gradient in Xenopus heart development, together with sFRP1 and heparan sulfate.

Authors:  Takayoshi Yamamoto; Yuta Kambayashi; Yuta Otsuka; Boni A Afouda; Claudiu Giuraniuc; Tatsuo Michiue; Stefan Hoppler
Journal:  Elife       Date:  2022-08-09       Impact factor: 8.713

7.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Proteoglycans in haemodialysis-related amyloidosis.

Authors:  K Ohashi; M Hara; M Yanagishita; R Kawai; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.

Authors:  Alexandra Abramsson; Sindhulakshmi Kurup; Marta Busse; Shuhei Yamada; Per Lindblom; Edith Schallmeiner; Denise Stenzel; Dominique Sauvaget; Johan Ledin; Maria Ringvall; Ulf Landegren; Lena Kjellén; Göran Bondjers; Jin-ping Li; Ulf Lindahl; Dorothe Spillmann; Christer Betsholtz; Holger Gerhardt
Journal:  Genes Dev       Date:  2007-02-01       Impact factor: 11.361

10.  Heparin sulfate-like immunoreactivity in the spinal cord in motor neuron disease.

Authors:  T Kato; T Katagiri; Y Shikama; K Kurita; I Toyoshima; A Hirano; M Wada; H Sasaki
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.